Genelux Corporation Common Stock (GNLX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $86.87M
Last updated: Nov 17, 2026 at 4:15 PM ET
Genelux Corporation Common Stock (GNLX) Statistics
Genelux Corporation Common Stock (GNLX) has a market cap of $86.87M and an enterprise value of $77.43M. It kept -474137.50% of revenue as net income over the last 12 months. Revenue fell 99.11% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 10.87% below the market cap, as cash exceeds debt.
| Market Cap | $86.87M |
|---|---|
| Enterprise Value | $77.43M |
| Latest price (Nov 17, 2026) | $2.00 |
Key Dates
| Last Earnings Date | Nov 16, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is down 62.41% over 52 weeks and trades 12.66% below its 50-day average.
| Beta (1Y) | 1.64 |
|---|---|
| 52-Week Change | -62.41% |
| 1-Month Change | -18.37% |
| 3-Month Change | -25.37% |
| 6-Month Change | -28.57% |
| Total Return (1Y) | -62.41% |
| Total Return (3Y CAGR) | -44.76% |
| Return vs SPY (1Y) | -72.03% |
| Max Drawdown (1Y) | -67.44% |
| Max Drawdown (3Y) | -89.99% |
| Sharpe Ratio (1Y) | -1.32 |
| Correlation with SPY (1Y) | 0.32 |
| 50-Day Average | $2.29 |
| 200-Day Average | $2.64 |
| 52-Week Range | $1.77 to $5.89 |
| RSI (14 Days) | 45.8 |
| Average Volume (20 Days) | 419.60K |
Financial Position
Current assets cover 1.16x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.16x |
|---|---|
| Quick Ratio | 1.16x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -413.28% and return on assets is -184.02% over the last 12 months.
| Return on Equity (ROE) | -413.28% |
|---|---|
| Return on Assets (ROA) | -184.02% |
| Asset Turnover | 0.00x |
Scores
GNLX has an Altman Z-Score of -22.52, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -22.52 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was $8.00K over the last 12 months.
| Revenue | $8.00K |
|---|---|
| Revenue Growth (YoY) | -99.11% |
| Gross Profit | $8.00K |
| Operating Income | -$38.63M |
| Pretax Income | -$37.93M |
| Net Income | -$37.93M |
| Reported EPS (TTM) | -$0.88 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 44.54% of the $20.61M in total assets.
| Cash and Equivalents | $9.45M |
|---|---|
| Total Debt | $0 |
| Net Cash | $9.45M |
| Net Cash Per Share | $0.21 |
| Working Capital | $1.52M |
| Shareholder Equity | $9.18M |
| Book Value Per Share | $0.20 |
| Total Assets | $20.61M |
| Total Liabilities | $11.43M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $5.61M of capital spending, operating cash flow left -$30.24M of free cash flow.
| Operating Cash Flow | -$24.63M |
|---|---|
| Capital Expenditures | $5.61M |
| Free Cash Flow | -$30.24M |
| FCF Per Share | -$0.67 |
| Depreciation and Amortization | $217.00K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -482812.50%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -482812.50% |
| Pretax Margin | -474137.50% |
| Net Margin | -474137.50% |
| FCF Margin | -377987.50% |
Growth
Revenue fell 91.03% a year over 3 years.
| Revenue Growth (3Y CAGR) | -91.03% |
|---|---|
| Book Value Per Share Growth (2Y CAGR) | -34.64% |
| Tangible Book Per Share Growth (2Y CAGR) | -34.64% |
Dividends and Yields
GNLX does not pay a dividend. Its free cash flow yield is -33.37%.
| FCF Yield | -33.37% |
|---|---|
| Buyback Yield | -21.57% |
| Shareholder Yield | -21.57% |
Analyst Forecast
Consensus estimates put revenue growth at 3032.23% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +3032.23% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About GNLX
What is GNLX's market cap?
Genelux Corporation Common Stock has a market cap of $86.87M. Its enterprise value, which adds debt and subtracts cash, is $77.43M.
How many shares of GNLX are outstanding?
Genelux Corporation Common Stock has 45.31M shares outstanding. The count is up 19.57% from a year earlier.
Does GNLX pay a dividend?
No. Genelux Corporation Common Stock does not pay a dividend.
How much debt does GNLX have?
Genelux Corporation Common Stock has $0 of total debt and $9.45M of cash and equivalents, a net cash position of $9.45M.
GNLX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors